Copyright
©The Author(s) 2021.
World J Clin Cases. Aug 16, 2021; 9(23): 6725-6733
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6725
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6725
Table 1 Clinical material of patients
Clinicopathological feature | Cases |
Age (yr) | |
≤ 50 | 45 |
> 50 | 43 |
Sex | |
Male | 45 |
Female | 43 |
Tumor diameter | |
< 5 cm | 50 |
≥ 5 cm | 38 |
TNM stage | |
I-II | 52 |
III | 36 |
Differentiation degree | |
High differentiation | 32 |
Medium/low differentiation | 56 |
Lymph node metastasis | |
Yes | 40 |
No | 48 |
Hepatitis B surface antigen positivity | |
Yes | 72 |
No | 16 |
Portal vein tumor thrombus | |
Yes | 50 |
No | 38 |
Table 2 Comparison of caspase-3 and hypoxia inducible factor 1α expression in hepatocellular carcinoma and paracancerous tissues, n (%)
Group | Cases | Positive expression rate of caspase-3 | Positive expression rate of HIF-1α |
HCC tissues | 88 | 24 (27.27) | 64 (72.73) |
Paracancerous tissues | 88 | 72 (81.82) | 28 (31.82) |
χ2 | 52.800 | 29.516 | |
P value | 0.000 | 0.000 |
Table 3 Relationship between expression of caspase-3 and hypoxia inducible factor 1α and clinical pathology of hepatocellular carcinoma, n (%)
Clinicopathological feature | Cases | Positive expression rate of caspase-3 | χ2 | P value | Positive expression rate of HIF-1α | χ2 | P value |
Age (yr) | 0.499 | 0.480 | 0.017 | 0.896 | |||
≤ 50 | 45 | 5 (11.11) | 33 (73.33) | ||||
> 50 | 43 | 7 (16.28) | 31 (72.09) | ||||
Sex | 0.288 | 0.591 | 0.121 | 0.728 | |||
Male | 45 | 7 (15.56) | 32 (71.11) | ||||
Female | 43 | 5 (11.63) | 32 (74.42) | ||||
Tumor diameter | 0.013 | 0.909 | 1.305 | 0.253 | |||
< 5 cm | 50 | 7 (14.00) | 34 (68.00) | ||||
≥ 5 cm | 38 | 5 (13.16) | 30 (78.95) | ||||
TNM stage | 4.639 | 0.031 | 5.502 | 0.019 | |||
I-II | 52 | 11 (21.15) | 33 (63.46) | ||||
III | 36 | 1 (2.78) | 31 (86.11) | ||||
Differentiation degree | 0.506 | 0.477 | 0.018 | 0.892 | |||
High differentiation | 32 | 4 (12.50) | 23 (71.88) | ||||
Medium/low differentiation | 56 | 8 (14.29) | 41 (73.21) | ||||
Lymph node metastasis | 7.723 | 0.005 | 11.619 | 0.001 | |||
Yes | 40 | 1 (2.50) | 22 (55.00) | ||||
No | 48 | 11 (22.92) | 42 (87.50) | ||||
HbsAg positivity | 0.000 | 1.000 | 0.497 | 0.481 | |||
Yes | 72 | 10 (13.89) | 54 (75.00) | ||||
No | 16 | 2 (12.50) | 10 (62.50) | ||||
Portal vein tumor thrombus | 0.013 | 0.909 | 13.617 | 0.035 | |||
Yes | 50 | 7 (14.00) | 44 (88.00) | ||||
No | 38 | 5 (13.16) | 22 (52.63) |
Table 4 Expression correlation of caspase-3 and hypoxia inducible factor 1α
Caspase-3 expression | HIF-1α | rs | P value | |
Positive | Negative | |||
Positive | 3 | 9 | -0.426 | 0.000 |
Negative | 61 | 15 |
Table 5 Multivariate analysis
Index | Hazard ratio (95%CI) | P value |
TNM stage | 1.822 (1.322-3.154) | 0.000 |
Portal vein tumor thrombus | 1.201 (1.092-2.822) | 0.000 |
Lymph node metastasis | 1.143 (1.022-2.560) | 0.000 |
Caspase-3 | 0.773 (0.573-0.882) | 0.000 |
HIF-1α | 1.211 (1.034-2.432) | 0.000 |
- Citation: Liang H, Wu JG, Wang F, Chen BX, Zou ST, Wang C, Luo SW. Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis. World J Clin Cases 2021; 9(23): 6725-6733
- URL: https://www.wjgnet.com/2307-8960/full/v9/i23/6725.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i23.6725